From histamine to imidazolylalkyl-sulfonamides: The design of a novel series of histamine H3-receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 13, 1999, Pages 1825-1830

  Tozer, Matthew J ^a   Harper, Elaine A ^a   Kalindjian, S Barret ^a   Pether, Michael J ^a   Shankley, Nigel P ^a   Watt, Gillian F ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE DERIVATIVE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; RECEPTOR; SULFONAMIDE;

ANIMAL TISSUE; ARTICLE; BIOASSAY; DRUG DESIGN; GUINEA PIG; ILEUM; LIGAND BINDING; MYENTERIC PLEXUS; NONHUMAN;

ANIMALS; DRUG DESIGN; GUINEA PIGS; HISTAMINE ANTAGONISTS; IMIDAZOLES; KINETICS; MODELS, CHEMICAL; RECEPTORS, HISTAMINE H3; SULFONAMIDES;

EID: 0033526927     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00272-3     Document Type: Article

References (24)

1. 1. Arrang, J.-M.; Garbarg, M.; Schwartz, J. C. Nature 1983, 302, 832.
2. 2. Leurs, R.; Blandina, P.; Tedford, C.; Timmerman, H. TiPS 1998, 19, 177.
3. 3-receptor antagonists has been the subject of a recent review: Stark, H.; Schlicker, E.; Schunack, W. Drugs Fut. 1996, 21, 507.
4. 4. James Black Foundation patent publication number WO 97/29092, 1997.
5. 4 a report of sulfonamide homologues of histamine has appeared. Wolin, R.; Connolly, M.; Afonso, A.; Hey, J. A.; She, H.; Rivelli, M. A.; Williams, S. M.; West, Jr., R. E. Bioorg. Med. Chem. Lett. 1998, 8, 2157.
6. 6. (a) Altman, J.; Shoef, N.; Wilchek, M.; Warshawsky, A. Isr. J. Chem. 1986, 27, 29.
7. (b) Warshawsky, A.; Altman, J.; Khana, R.; Arad-Yellin, R.; Deshe, A.; Hasson, H.; Shoef, N.; Gottlieb, H. Synth. 1989, 825.
8. 7. Emmett, J. C.; Holloway, F.H.; Turner, J. L. J. C. S. Perkin I 1979, 1341.
9. 8. Vollinga, R. C.; Wiro, W. M. P. B.; Leurs, R.; Timmerman, H. J. Med. Chem. 1995, 38, 266.
10. 9. (a) Watt, G. F.; Hamilton, L. C.; Shankley, N. P.; Black, J. W. Br. J. Pharmacol. 1997, 122, 434P.
11. (b) Trzeciakowski, J. P. J. Pharmacol. Exp. Ther. 1987, 243, 874.
12. 10. (a) Harper, E. A.; Shankley, N. P.; Black, J. W. Br. J. Pharmacol. 1997, 122, 430P.
13. (b) Harper, E. A.; Gardner, B.; Griffin, E. P.; Shankley, N. P.; Black, J. W. Br. J. Pharmacol. 1997 122, 431P.
14. 11. Arrang, J.-M.; Garbarg, M.; Lancelot, J.-C.; Lecomte, J.-M.; Pollard, H.; Robba, M.; Schwartz, J. C. Nature 1987, 327, 832.
15. 12. Kent, R. S.; De Lean, A.; Lefkowitz, R. J. Mol. Pharmacol. 1980, 17, 14.
16. 13. Stark, H.; Purand, K.; Hüls, A.; Ligneau, Garbarg, M.; Schwartz, J.-C.; Schunack, W. J. Med. Chem. 1996, 39, 1220.
17. 14. Low, C. M. R.; Vinter, J. G.; Kalindjian, S. B.; Pether, M. J. Br. J. Pharmacol. 1997, 122, 433P.
18. 15. Watt, G. F.; Sykes, D. A.; Roberts, S. P.; Shankley, N. P.; Black, J. W. Br. J. Pharmacol. 1997, 122, 435P.
19. 16. Schlicker, E.; Kathmann, M.; Bitschau, H.; Marr, L; Reidemeister, S.; Stark, H.; Schunack, W. NaunynSchmeideberg's Arch. Pharmacol. 1996, 353, 482.
20. 17. Harper, E. A.; Shankley, N. P.; Black, J. W. Br. J. Pharmacol. 1997 122, 429P.
21. 18. Kenakin, T. P.; Beak, D. J. Pharmacol. Exp. Ther. 1980, 213, 406.
22. 21 compound 9 was found to be inactive at 30μM in the guinea pig right atrium assay.
23. 20. Watt, G. F.; Shankley, N. P.; Black, J. W. Br. J. Pharmacol. 1995 114(suppl.), 260.
24. 21. Angus, J. A.; Black, J. W. Circ. Res. 1980, 65, 1.